The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Abstract
OBJECTIVE: The authors evaluated the efficacy and safety of lurasidone in the treatment of patients with major depressive episodes associated with bipolar I disorder. METHOD: Patients were randomly assigned to receive double-blind treatment with lurasidone (20-60 mg/day [N=166] or 80-120 mg/day [N=169]) or placebo (N=170) for 6 weeks. Primary and key secondary endpoints were change from baseline to week 6 on the Montgomery-Åsberg Depression Rating Scale (MADRS) and depression severity score on the Clinical Global Impressions scale for use in bipolar illness (CGI-BP), respectively. RESULTS: Lurasidone treatment significantly reduced mean MADRS total scores at week 6 for both the 20-60 mg/day group (-15.4; effect size=0.51) and the 80-120 mg/day group (-15.4; effect size=0.51) compared with placebo (-10.7). Similarly, lurasidone treatment resulted in significantly greater endpoint reduction in CGI-BP depression severity scores for both the 20-60 mg/day group (-1.8; effect size=0.61) and the 80-120 mg/day group (-1.7; effect size=0.50) compared with placebo (-1.1). Both lurasidone groups also experienced significant improvements compared with placebo in anxiety symptoms and in patient-reported measures of quality of life and functional impairment. Discontinuation rates due to adverse events were similar in the 20-60 mg/day (6.6%), 80-120 mg/day (5.9%), and placebo (6.5%) groups. The most frequent adverse events associated with lurasidone were nausea, headache, akathisia, and somnolence. Minimal changes in weight, lipids, and measures of glycemic control were observed with lurasidone. CONCLUSION: Monotherapy with lurasidone in the dosage range of 20-120 mg/day significantly reduced depressive symptoms in patients with bipolar I depression. Lurasidone was well tolerated, with few changes in weight or metabolic parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 1×
“Treatment-emergent mania was defined a priori as a Young Mania Rating Scale (YMRS [31]) score $16 on any two consecutive visits, or at the final assessment, or an adverse event of mania or hypomania.”
MethodVos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
(1993) · PubMed · Cited by 1,900
Spearing, M. K., Post, R. M., Leverich, G. S., Brandt, D., & Nolen, W. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00123-6 · Cited by 978
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationSheehan, D. V. (1984) · Medical Entomology and Zoology · Cited by 883
Vancampfort, D., Vansteelandt, K., Correll, C. U., Mitchell, A. J., De Herdt, A., Sienaert, P., Probst, M., & De Hert, M. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050620 · Cited by 441
Ishibashi, T., Horisawa, T., Tokuda, K., Ishiyama, T., Ogasa, M., Tagashira, R., Matsumoto, K., Nishikawa, H., Ueda, Y., Toma, S., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167346 · Cited by 438
Multiple Comparisons and Multiple Tests Using the SAS System
ROM, D. M., Tobias, R. D., & Wolfinger, R. D. (1999) · Cited by 436
Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., Keck, P. E., McElroy, S. L., Denicoff, K. D., Obrocea, G., Nolen, W. A., Kupka, R., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0503 · Cited by 352
Antidepressants for the Acute Treatment of Bipolar Depression: A Systematic Review and Meta-Analysis
Sidor, M. M., & MacQueen, G. M. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05385gre · Cited by 308
A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania
Ninan, P. T., Rothbaum, B. O., Marsteller, F. A., Knight, B. T., & Eccard, M. B. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0111 · Cited by 303
Jamison, K. R. (2019) · The Science of Mental Health · doi:10.4324/9781315054308-12 · Cited by 264
Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States
Goldstein, B. I., Fagiolini, A., Houck, P., & Kupfer, D. J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00735.x · Cited by 259
Thase, M. E., Jonas, A., Khan, A., Bowden, C. L., Wu, X., McQuade, R. D., Carson, W. H., Marcus, R. N., & Owen, R. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181618eb4 · Cited by 251
The 5-HT7 receptor and disorders of the nervous system: an overview
Hedlund, P. B. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1626-0 · Cited by 239
Calabrese, J. R., Hirschfeld, R. M. A., Frye, M. A., & Reed, M. L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1109 · Cited by 211
Prevalence, chronicity, burden and borders of bipolar disorder
Fagiolini, A., Forgione, R., Maccari, M., Cuomo, A., Morana, B., Dell'Osso, M. C., Pellegrini, F., & Rossi, A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.001 · Cited by 194
Predicting the course and outcome of bipolar disorder: A review
Treuer, T., & Tohen, M. F. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2009.11.012 · Cited by 136
Tohen, M. F., McDonnell, D., Case, M. G., Kanba, S., Ha, K., Fang, Y., Katagiri, H., & Gomez, J.-C. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.108357 · Cited by 127
Strategies for improving treatment of bipolar disorder: integration of measurement and management
Sachs, G. S. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00409.x · Cited by 123
Self-citationEvidence‐based treatment strategies for treatment‐resistant bipolar depression: a systematic review
Sienaert, P. A., Lambrichts, L., Dols, A., & Fruyt, J. D. (2012) · Bipolar Disorders · doi:10.1111/bdi.12026 · Cited by 113
Sachs, G. S., Ice, K. S., Chappell, P. B., Schwartz, J. H., Gurtovaya, O., Vanderburg, D. G., & Kasuba, B. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05934 · Cited by 101
Self-citationFruyt, J. D., Deschepper, E., Audenaert, K., Constant, E., Floris, M., Pitchot, W., Sienaert, P. A., Souery, D., & Claes, S. J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408461 · Cited by 100
Khan, A., Kolts, R. L., Thase, M. E., Krishnan, K., & Brown, W. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2045 · Cited by 98
Bech, P., Tanghøj, P., Andersen, H. F., & Overø, K. F. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1147-6 · Cited by 91
Effects of lurasidone in behavioral models of depression. Role of the 5-HT7 receptor subtype
Cates, L. N., Roberts, A. J., Huitrón‐Reséndiz, S., & Hedlund, P. B. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.023 · Cited by 91
Quetiapine: A Review of its Use in the Management of Bipolar Depression
Sanford, M., & Keating, G. M. (2012) · CNS Drugs · doi:10.2165/11203840-000000000-00000 · Cited by 81
Lombardo, I., Sachs, G. S., Kolluri, S., Kremer, C. M. E., & Yang, R. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31825ccde5 · Cited by 74
Self-citationLieshout, R. J. V., & MacQUEEN, G. M. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.057612 · Cited by 63
Parker, G. B., McCraw, S., Hadži-Pavlović, D., & Fletcher, K. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.002 · Cited by 46
Initial Validity and Reliability Data on the Columbia–Suicide Severity Rating Scale
Chappell, P. B., Feltner, D. E., Makumi, C. W., & Stewart, M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010123 · Cited by 34
Cited by
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“…olanzapine (Tohen et al., 2003c, 2012), quetiapine (Calabrese et al., 2005b; McElroy et al., 2010; Thase, 2006; Young et al., 2010) and lurasidone (Loebel et al., 2014a, 2014b) are effective treatments for bipolar depression, but these studies have significant methodological issues that moderate…”
BackgroundGeddes, J. R., & Miklowitz, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60857-0 · Cited by 848
Malhi, G. S., Bell, E., Bassett, D., Boyce, P., Bryant, R., Hazell, P., Hopwood, M., Lyndon, B., Mulder, R., Porter, R., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420979353 · Cited by 614
Metadata
- Authors
- Loebel, A., Cucchiaro, J., Silva, R., Kroger, H., Hsu, J., Sarma, K., & Sachs, G.
- Venue
- American Journal of Psychiatry
- Published
- 2014-02
- Volume
- 171
- Issue
- 2
- Pages
- 160-168
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2163368530
- Cited by
- 341
- References
- 39
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.